83 FR 49561 - National Cancer Institute; Notice of Charter Renewal

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 191 (October 2, 2018)

Page Range		49561-49562
FR Document		2018-21372

Federal Register, Volume 83 Issue 191 (Tuesday, October 2, 2018)

[Federal Register Volume 83, Number 191 (Tuesday, October 2, 2018)]
[Notices]
[Pages 49561-49562]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-21372]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Charter Renewal

    In accordance with Title 41 of the U.S. Code of Federal 
Regulations, Section 102-3.65(a), notice is hereby given that the 
Charter for the National Cancer Institute Council of Research Advocates 
was renewed for an

[[Page 49562]]

additional two-year period on August 17, 2018.
    It is determined that the National Cancer Institute Council of 
Research Advocates is in the public interest in connection with the 
performance of duties imposed on the National Cancer Institute and 
National Institutes of Health by law, and that these duties can best be 
performed through the advice and counsel of this group.
    Inquiries may be directed to Claire Harris, Acting Director, Office 
of Federal Advisory Committee Policy, Office of the Director, National 
Institutes of Health, 6701 Democracy Boulevard, Suite 1000, Bethesda, 
Maryland 20892 (Mail Stop Code 4875), [email protected] or Telephone 
(301) 496-2123.

    Dated: September 26, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-21372 Filed 10-1-18; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 83, No. 191 / Tuesday, October 2, 2018 / Notices 49561

requesting information, please include enhance the quality, utility, and clarity Prevention (TPP) grant recipients,
the document identifier 0990–New–60D of the information to be collected; and anticipated to be awarded in September
and project title for reference, to (4) the use of automated collection 2018. OAH released a funding
Sherrette.funn@hhs.gov, or call the techniques or other forms of information announcement to support Phase 1 of a
Reports Clearance Officer, (202) 795– technology to minimize the information third cohort of TPP grantees in the
7714. collection burden. spring of 2018, subject to the availability
SUPPLEMENTARY INFORMATION: Interested Title of the Collection: Cohort 3 Teen of funding, with awards expected to be
persons are invited to send comments Pregnancy Prevention (TPP) Program made in September 2018. Phase 1 cohort
regarding this burden estimate or any Performance Measures. 3 TPP grants shall be issued in for an
other aspect of this collection of Type of Collection: New. anticipated 2 year period of
information, including any of the OMB No. 0990–NEW—Office of performance. A subset of successful
following subjects: (1) The necessity and Adolescent Health, OS. Phase 1 grantees will be selected for
utility of the proposed information Abstract: The Office of Adolescent Phase 2 grants. A 3 year clearance is
collection for the proper performance of Health Requests a new clearance for the requested for this request. TPP phase 1
the agency’s functions; (2) the accuracy collection of performance measures grant recipients will be expected to
of the estimated burden; (3) ways to from the cohort 3 Teen Pregnancy report data twice each year.

ANNUALIZED BURDEN HOUR TABLE
Number of Average
Forms Respondents Number of Total burden
responses per burden per
(if necessary) (if necessary) respondents hours
respondents response

TPP Grantees, Performance Meas- Grant Recipients .............................. 60 2 7 840
ures Form.
TPP Participants Pre/Post Test Grant Recipients .............................. 60 2 3 360
Compilation.
TPP Participants Pre/Post Test ........ Participants in TPP-grant funded 45,000 2 5/60 7,500
projects.

Total ........................................... ........................................................... ........................ 2 ........................ 8,700

Terry Clark, and personal information concerning government-issued photo ID, driver’s license,
Office of the Secretary, Asst. Paperwork individuals associated with the grant or passport) and to state the purpose of their
Reduction Act Reports Clearance Office. applications, the disclosure of which visit.
would constitute a clearly unwarranted Information is also available on the
[FR Doc. 2018–21402 Filed 10–1–18; 8:45 am]
Institute’s/Center’s home page:
BILLING CODE 4168–11–P invasion of personal privacy. www.nhlbi.nih.gov/meetings/nhlbac/
Name of Committee: National Heart, Lung, index.htm, where an agenda and any
and Blood Advisory Council. additional information for the meeting will
DEPARTMENT OF HEALTH AND Date: October 30, 2018. be posted when available.
HUMAN SERVICES Open: 8:00 a.m. to 12:00 p.m. (Catalogue of Federal Domestic Assistance
Agenda: To discuss program policies and Program Nos. 93.233, National Center for
National Institutes of Health issues. Sleep Disorders Research; 93.837, Heart and
Place: National Institutes of Health, Porter Vascular Diseases Research; 93.838, Lung
National Heart, Lung, and Blood Neuroscience Research Center, Building 35A Diseases Research; 93.839, Blood Diseases
Institute; Notice of Meeting Convent Drive, Bethesda, MD 20892. and Resources Research, National Institutes
Closed: 12:30 p.m. to 4:00 p.m. of Health, HHS)
Pursuant to section 10(d) of the Agenda: To review and evaluate grant
Federal Advisory Committee Act, as applications. Dated: September 26, 2018.
amended, notice is hereby given of a Place: National Institutes of Health, Porter Ronald J. Livingston, Jr.,
Neuroscience Research Center, Building 35A Program Analyst Office of Federal Advisory
meeting of the National Heart, Lung, Convent Drive, Bethesda, MD 20892.
and Blood Advisory Council. Committee Policy.
Contact Person: Laura K. Moen, Ph.D.,
The meeting will be open to the Director, Division of Extramural Research [FR Doc. 2018–21371 Filed 10–1–18; 8:45 am]
public as indicated below, with Activities National Heart, Lung, and Blood BILLING CODE 4140–01–P
attendance limited to space available. Institute, National Institutes of Health, 6701
Individuals who plan to attend and Rockledge Drive, Room 7100, Bethesda, MD
20892, 301–435–0260, moenl@mail.nih.gov. DEPARTMENT OF HEALTH AND
need special assistance, such as sign
language interpretation or other Any interested person may file written HUMAN SERVICES
comments with the committee by forwarding
reasonable accommodations, should the statement to the Contact Person listed on National Institutes of Health
notify the Contact Person listed below this notice. The statement should include the
in advance of the meeting. name, address, telephone number and when National Cancer Institute; Notice of
The meeting will be closed to the applicable, the business or professional Charter Renewal
amozie on DSK3GDR082PROD with NOTICES1

public in accordance with the affiliation of the interested person.
provisions set forth in sections In the interest of security, NIH has In accordance with Title 41 of the
instituted stringent procedures for entrance
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., onto the NIH campus. All visitor vehicles,
U.S. Code of Federal Regulations,
as amended. The grant applications and including taxicabs, hotel, and airport shuttles Section 102–3.65(a), notice is hereby
the discussions could disclose will be inspected before being allowed on given that the Charter for the National
confidential trade secrets or commercial campus. Visitors will be asked to show one Cancer Institute Council of Research
property such as patentable material, form of identification (for example, a Advocates was renewed for an

VerDate Sep<11>2014 18:39 Oct 01, 2018 Jkt 247001 PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 E:\FR\FM\02OCN1.SGM 02OCN1

49562 Federal Register / Vol. 83, No. 191 / Tuesday, October 2, 2018 / Notices

additional two-year period on August This notice is also available on the 784–1190 (Formerly: Gamma-
17, 2018. internet at http://www.samhsa.gov/ Dynacare Medical Laboratories)
It is determined that the National workplace.
HHS-Certified Laboratories
Cancer Institute Council of Research FOR FURTHER INFORMATION CONTACT:
Advocates is in the public interest in ACM Medical Laboratory, Inc., 160
Charles LoDico, Division of Workplace Elmgrove Park, Rochester, NY 14624,
connection with the performance of Programs, SAMHSA/CSAP, 5600
duties imposed on the National Cancer 844–486–9226
Fishers Lane, Room 16N02C, Rockville,
Institute and National Institutes of Alere Toxicology Services, 1111 Newton
Maryland 20857; 240–276–2600 (voice).
Health by law, and that these duties can St., Gretna, LA 70053, 504–361–8989/
SUPPLEMENTARY INFORMATION: The 800–433–3823 (Formerly: Kroll
best be performed through the advice
and counsel of this group. Department of Health and Human Laboratory Specialists, Inc.,
Services (HHS) notifies federal agencies Laboratory Specialists, Inc.)
Inquiries may be directed to Claire of the laboratories and Instrumented Alere Toxicology Services, 450
Harris, Acting Director, Office of Federal Initial Testing Facilities (IITF) currently Southlake Blvd., Richmond, VA
Advisory Committee Policy, Office of certified to meet the standards of the 23236, 804–378–9130 (Formerly:
the Director, National Institutes of Mandatory Guidelines for Federal Kroll Laboratory Specialists, Inc.,
Health, 6701 Democracy Boulevard, Workplace Drug Testing Programs Scientific Testing Laboratories, Inc.;
Suite 1000, Bethesda, Maryland 20892 (Mandatory Guidelines). The Mandatory Kroll Scientific Testing Laboratories,
(Mail Stop Code 4875), harriscl@nih.gov Guidelines were first published in the Inc.)
or Telephone (301) 496–2123. Federal Register on April 11, 1988 (53 Baptist Medical Center-Toxicology
Dated: September 26, 2018. FR 11970), and subsequently revised in Laboratory, 11401 I–30, Little Rock,
Melanie J. Pantoja, the Federal Register on June 9, 1994 (59 AR 72209–7056, 501–202–2783
Program Analyst, Office of Federal Advisory FR 29908); September 30, 1997 (62 FR (Formerly: Forensic Toxicology
Committee Policy. 51118); April 13, 2004 (69 FR 19644); Laboratory Baptist Medical Center)
[FR Doc. 2018–21372 Filed 10–1–18; 8:45 am] November 25, 2008 (73 FR 71858); Clinical Reference Laboratory, Inc., 8433
BILLING CODE 4140–01–P December 10, 2008 (73 FR 75122); April Quivira Road, Lenexa, KS 66215–
30, 2010 (75 FR 22809); and on January 2802, 800–445–6917
23, 2017 (82 FR 7920). Cordant Health Solutions, 2617 East L
DEPARTMENT OF HEALTH AND The Mandatory Guidelines were Street, Tacoma, WA 98421, 800–442–
HUMAN SERVICES initially developed in accordance with 0438 (Formerly: STERLING Reference
Executive Order 12564 and section 503 Laboratories)
Substance Abuse and Mental Health of Public Law 100–71. The ‘‘Mandatory DrugScan, Inc., 200 Precision Road,
Services Administration Guidelines for Federal Workplace Drug Suite 200, Horsham, PA 19044, 800–
Testing Programs,’’ as amended in the 235–4890
Current List of HHS-Certified revisions listed above, requires strict
Laboratories and Instrumented Initial Dynacare*, 245 Pall Mall Street,
standards that laboratories and IITFs London, ONT, Canada N6A 1P4, 519–
Testing Facilities Which Meet Minimum must meet in order to conduct drug and
Standards To Engage in Urine Drug 679–1630 (Formerly: Gamma-
specimen validity tests on urine Dynacare Medical Laboratories)
Testing for Federal Agencies specimens for federal agencies. ElSohly Laboratories, Inc., 5 Industrial
AGENCY: Substance Abuse and Mental To become certified, an applicant Park Drive, Oxford, MS 38655, 662–
Health Services Administration, HHS. laboratory or IITF must undergo three 236–2609
rounds of performance testing plus an Laboratory Corporation of America
ACTION: Notice. on-site inspection. To maintain that Holdings, 7207 N Gessner Road,
certification, a laboratory or IITF must Houston, TX 77040, 713–856–8288/
SUMMARY: The Department of Health and participate in a quarterly performance 800–800–2387
Human Services (HHS) notifies federal testing program plus undergo periodic, Laboratory Corporation of America
agencies of the laboratories and on-site inspections. Holdings, 69 First Ave., Raritan, NJ
Instrumented Initial Testing Facilities Laboratories and IITFs in the 08869, 908–526–2400/800–437–4986
(IITF) currently certified to meet the applicant stage of certification are not to (Formerly: Roche Biomedical
standards of the Mandatory Guidelines be considered as meeting the minimum Laboratories, Inc.)
for Federal Workplace Drug Testing requirements described in the HHS Laboratory Corporation of America
Programs (Mandatory Guidelines). Mandatory Guidelines. A HHS-certified Holdings, 1904 TW Alexander Drive,
A notice listing all currently HHS- laboratory or IITF must have its letter of Research Triangle Park, NC 27709,
certified laboratories and IITFs is certification from HHS/SAMHSA 919–572–6900/800–833–3984
published in the Federal Register (formerly: HHS/NIDA), which attests (Formerly: LabCorp Occupational
during the first week of each month. If that it has met minimum standards. Testing Services, Inc., CompuChem
any laboratory or IITF certification is In accordance with the Mandatory Laboratories, Inc.; CompuChem
suspended or revoked, the laboratory or Guidelines dated January 23, 2017 (82 Laboratories, Inc., A Subsidiary of
IITF will be omitted from subsequent FR 7920), the following HHS-certified Roche Biomedical Laboratory; Roche
lists until such time as it is restored to laboratories and IITFs meet the CompuChem Laboratories, Inc., A
full certification under the Mandatory minimum standards to conduct drug Member of the Roche Group)
amozie on DSK3GDR082PROD with NOTICES1

Guidelines. and specimen validity tests on urine Laboratory Corporation of America
If any laboratory or IITF has specimens: Holdings, 1120 Main Street,
withdrawn from the HHS National Southaven, MS 38671, 866–827–8042/
HHS-Certified Instrumented Initial
Laboratory Certification Program (NLCP) 800–233–6339 (Formerly: LabCorp
Testing Facilities
during the past month, it will be listed Occupational Testing Services, Inc.;
at the end and will be omitted from the Dynacare, 6628 50th Street NW, MedExpress/National Laboratory
monthly listing thereafter. Edmonton, AB Canada T6B 2N7, 780– Center)

VerDate Sep<11>2014 17:16 Oct 01, 2018 Jkt 247001 PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 E:\FR\FM\02OCN1.SGM 02OCN1

Document Created: 2018-10-02 01:18:32
Document Modified: 2018-10-02 01:18:32

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
FR Citation		83 FR 49561

83 FR 49561 - National Cancer Institute; Notice of Charter Renewal

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 83, Issue 191 (October 2, 2018)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health